U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Officials say while a third shot helps protect against hospitalization and death, it’s not that good at protecting against infections.
A COVID-19 antiviral treatment for children could soon be on the way.
U.S. regulators have put the brakes on their push to speed Pfizer’s COVID-19 to children under 5. Friday’s move creates major uncertainty about how soon the shots could become available.
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old. That’s according to a person familiar with the matter who spoke on the condition of anonymity to discuss sensitive regulatory issues.
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
The Centers for Disease Control and Prevention has signed off on two measures to increase access to additional doses of the Pfizer coronavirus vaccine.
Parents with children under 5-years-old will have to wait a bit longer for a COVID-19 vaccine for their kids.
The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.
The CDC has updated its recommendations on COVID-19 vaccines after its vaccine advisors met on Thursday. This comes as the Omicron variant continues to spread in the U.S.
